WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, Invivyd intends to grant the underwriters an option for a period of 30 days to purchase up to an additional 15% of the shares of Invivyd common stock sold in the public offering at the public offering price, less underwriting discounts and commissions. All of the shares are being offered by Invivyd. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Related Questions
How many shares are being offered and at what price range, and what dilution effect will this have on existing shareholders?
What are the underwriting terms, including fees and the size of the over‑allotment option, and how might they affect the net proceeds?
How does this capital raise compare to Invivyd’s recent financing activity and its peers' equity offerings in terms of valuation and strategic purpose?